The molecular genetics of the tauopathies

Experimental Gerontology

Volumn 35, Issue 4, 2000, Pages 461-471

  Van Slegtenhorst, M ^a   Lewis, J ^a   Hutton, M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Neurodegenerative diseases; Tauopathies

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; CHROMOSOME 17; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DELETION MUTANT; EXON; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC LINKAGE; HAPLOTYPE; MISSENSE MUTATION; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; RISK FACTOR;

ALZHEIMER DISEASE; DEMENTIA; HUMANS; MOLECULAR BIOLOGY; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; TAU PROTEINS;

EID: 0034233290     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(00)00114-5     Document Type: Review

References (31)

1. Baker M., et al. Association of an extended haplotype in the tau gene with Progressive Supranuclear Palsy. Hum. Mol. Genet. 8:1999;711-715.
2. Brion J.P., et al. Transgenic expression of the shortest human tau affects its compartimentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. Am. J. Pathol. 154:1999;255-270.
3. Conrad C., et al. Genetic evidence of the involvement of τ in Progressive Supranuclear Palsy. Ann. Neurol. 41:1997;277-281.
4. Dayanandan R., et al. Mutations in tau reduce its microtubule-binding properties in intact living cells. FEBS Lett. 446:1999;228-232.
5. Dickson D. Neurodegenerative diseases with cytoskeletal pathology: a biochemical classification. Ann. Neurol. 42:1997;541-543.
6. D'Souza I., et al. Missense and silent tau gene mutations cause frontotemporal dementia with parkisonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl Acad. Sci. USA. 96:1999;5598-5603.
7. Foster N.L., et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann. Neurol. 41:1997;706-715. Review.
8. Friedhoff P., et al. A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc. Natl Acad. Sci. USA. 95:1998;15712-15717.
9. Goedert M., et al. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8:1989;393-399.
10. Goedert M., et al. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett. 450:1999;306-311.
11. Götz J., et al. Somatodendritic localisation and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J. 14:1995;1304-1313.
12. Grover A., et al. 5′ Splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J. Biol. Chem. 274:1999;15134-15143.
13. Hardy J., et al. Genetic dissection of Alzheimer's and related dementias: amyloid and its relationship to Tau. Nature Neurosci. 1:1998;355-358.
14. Hasegawa M., et al. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett. 437:1998;207-210.
15. Hong H., et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science. 282:1998;1914-1917.
16. Hutton M., et al. Association of missense and 5(-splice mutations in tau with the inherited dementia FTDP-17. Nature. 393:1998;702-705.
17. Hutton M. Missense and splicing mutations in tau associated with FTDP-17: multiple pathogenic mechanisms. Neurosci. News. 2:1999;73-82.
18. Ishihara T., et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron. 24:1999;751-762.
19. Kosik K. Developmentally regulated expression of specific tau sequences. Neuron. 2:1989;1389-1397.
20. Lee G., et al. The microtubule binding domain of Tau protein. Neuron. 2:1989;1615-1624.
21. Litvan I., Hutton M. Clinical and genetic aspects of progressive supranuclear palsy. J. Geriatr. Psychiatry Neurol. 11:1998;107-114.
22. LoPresti P., et al. Functional implications for the microtubule -associated protein Tau: localisation in oligodendrocytes. Proc. Natl Acad. Sci. USA. 92:1995;10369-10373.
23. Nacharaju P., et al. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett. 447:1999;195-199.
24. Poorkaj P., et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43:1998;815-825.
25. Probst A., et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol (Berl). 99:2000;469-481.
26. Rizzu P., et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am. J. Hum. Genet. 64:1999;414-421.
27. Spillantini M.G., et al. Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: a new group of Tauopathies. Brain Pathol. 8:1998a;387-402.
28. Spillantini M.G., et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA. 95:1998b;7737-7741.
29. Spittaels K., et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol. 155:1999;2153-2165.
30. Varini, et al. Structure of tau exon 10 splicing regulatory element RNA and destabilisation by mutation of Frontotemporal Dementia and Parkinsonism linked to Chromosome 17. Proc. Natl Acad. Sci. USA. 96:1999;8229-8234.
31. Yen S., et al. FTDP-17 tau mutations decrease the susceptibility of tau to calpain digestion. FEBS Lett. 461:1999;91-95.